A synthetic vaccine against influenza with built-in adjuvanticity
- 1 January 1985
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 7 (5), 719-723
- https://doi.org/10.1016/0192-0561(85)90157-2
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin.Proceedings of the National Academy of Sciences, 1984
- Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infectionInternational Journal of Immunopharmacology, 1983
- A modified ELISA technique for anti-hapten antibodiesJournal of Immunological Methods, 1982
- Castration of male mice by a synthetic LH-RH-MDP conjugate administered in salineInternational Journal of Immunopharmacology, 1982
- An Analysis of Effector T Cell Generation and Function in Mice Exposed to Influenza A or Sendai VirusesImmunological Reviews, 1981
- Enzyme immunoassays with special reference to ELISA techniques.Journal of Clinical Pathology, 1978
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- Adjuvant activity in delayed hypersensitivity of the peptidic part of bacterial peptidoglycansNature, 1974
- Adjuvant activity of monomeric bacterial cell wall peptidoglycansBiochemical and Biophysical Research Communications, 1974